Article
Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Dec 2009
Meza Nestor W, Alonso-Ferrero Maria E, Navarro Susana, Quintana-Bustamante Oscar, Valeri Antonio, Garcia-Gomez Maria, Bueren Juan A, Bautista Jose M, Segovia Jose C
Abstract excerpt
Human erythrocyte R-type pyruvate kinase deficiency (PKD) is a disorder caused by mutations in the PKLR gene that produces chronic nonspherocytic hemolytic anemia. Besides periodic blood transfusion and splenectomy, severe cases require bone marrow (BM) transplant, which makes this disease a good candidate for gene therapy. Here, the normal human R-type pyruvate kinase (hRPK) complementary (cDNA) was expressed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
